Rohto Pharmaceutical: Consolidated financial results for the first quarter of the fiscal year ending March 31, 2025 (three months until June 30, 2024).

JPX · Aug 7 14:00

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.